Effect of celecoxib (CLX) and sorafenib (SOR) individually and in combination on expression levels of survivin, DKK1, YAP1, CHOP and TRB3 proteins.

<p>Cells were treated for 48 h with the indicated concentrations of CLX and SOR and their combinations. After treatment cells were harvested and lysed and equal amounts of extracted protein were analyzed for survivin, DKK1, YAP1, CHOP and TRB3 expression by Western blotting. The data represent two independent experiments with comparable outcomes.